The fall and rise of prostate‐specific antigen: Kinetics of serum prostate‐specific antigen levels after radiation therapy for prostate cancer

Cancer

Volumn 72, Issue 3, 1993, Pages 832-842

  Zagars, Gunar K ^a   Pollack, Alan ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

cytokinetics; prostate cancer; prostate specific antigen; radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CELL KINETICS; CORRELATION FUNCTION; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN BLOOD LEVEL;

ACTUARIAL ANALYSIS; ADENOCARCINOMA; AGED; AGED, 80 AND OVER; HUMAN; KINETICS; MALE; MIDDLE AGE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027200803     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930801)72:3<832::AID-CNCR2820720332>3.0.CO;2-6     Document Type: Article

References (29)

1. Prostate‐specific antigen and external beam radiotherapy in prostate cancer
2. Prostate‐specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy
3. Prostate‐specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer
4. A prospective study of prostate specific antigen levels in patients receiving radiotherapy for localized carcinoma of the prostate
5. Prostatic specific antigen as an indicator of response to radiotherapy in prostate cancer
6. Prostate‐specific antigen as a serum marker for adenocarcinoma of the prostate
7. A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapy
8. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate: I. Untreated patients
9. Prostate‐specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy
10. Histologic grading study of prostate adenocarcinoma: the development of a new system and comparison with other methods. A preliminary study
11. The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy
12. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy
13. Potential value of cell kinetics in management of cancers of unknown origin
14. The proliferative pattern of the prostatic carcinoma before and under hormonal treatment
15. Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies
16. Immunocytochemical demonstration of S phase cells by anti‐bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma
17. Relation between the pathological nature and the growth rate of human tumors
18. Cell loss from experimental tumors
19. Presidential address of the 24th Annual Meeting of the American Society of Therapeutic Radiologists. Carcinoma of the prostate: a vexing biological and clinical enigma
20. Stage C adenocarcinoma of the prostate: an analysis of 551 patients treated with external beam radiation
21. The lack of prognostic significance of biopsies after radiotherapy for prostatic cancer